Charles River Laboratories completed the acquisition of Explora BioLabs for $295m.

Charles River Laboratories, a pharmaceutical company, completed the acquisition of Explora BioLabs, a provider of contract vivarium research services, for $295m. “With its presence in West Coast biohubs, the acquisition of Explora BioLabs complements our existing CRADL™ footprint and offers incremental opportunities to partner with an emerging, high-growth client base, many of which are engaged in cell and gene therapy development," James Foster, Charles River Laboratorie Chairman, President and CEO.